GB2037565A - Electrolyte drink - Google Patents

Electrolyte drink Download PDF

Info

Publication number
GB2037565A
GB2037565A GB7941451A GB7941451A GB2037565A GB 2037565 A GB2037565 A GB 2037565A GB 7941451 A GB7941451 A GB 7941451A GB 7941451 A GB7941451 A GB 7941451A GB 2037565 A GB2037565 A GB 2037565A
Authority
GB
United Kingdom
Prior art keywords
ions
mixture
sodium
phosphate
meq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB7941451A
Other versions
GB2037565B (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vitapharm Pharmaceutical Pty Ltd
Original Assignee
Vitapharm Pharmaceutical Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vitapharm Pharmaceutical Pty Ltd filed Critical Vitapharm Pharmaceutical Pty Ltd
Publication of GB2037565A publication Critical patent/GB2037565A/en
Application granted granted Critical
Publication of GB2037565B publication Critical patent/GB2037565B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385Concentrates of non-alcoholic beverages
    • A23L2/39Dry compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A chemical composition for reconstituting with water to provide an electrolyte drink intended for consumption by animals, especially human beings. The drink permits replacement of essential body constituents lost as a result of metabolic processes. The composition comprises Na<+>, K<+>, Mg<2+>, Cl<->, SO42-, PO42-, citrate, sucrose, dextrose, ascorbic acid and pyridoxine.

Description

SPECIFICATION Electrolyte drink This invention relates to an electrolyte drink useful for replenishing the major constituents lost from body fluids as a result of metabolic processes. While the drink is mainly intended for use by humans and is described in that context, it is to be understood that it can equally be used by animals such as horses and dogs.
There are presently a substantial number of electrolyte drinks on the market which are alleged to replenish essential electrolytes and water lost from the body during physical activity. Such products are, however, generally unpalatable and do not, in fact, satisfy the body completely by replenishing all the essential constituents which are lost.
It is therefore an object of the invention to provide a drink which overcomes these defects and, furthermore, permits quick recovery of the body following strenuous activity.
The invention is based upon a number of new discoveries and known scientific data which can be summarized as follows: (1) The unpleasant taste of electrolytes in drinks can be masked by carefully balancing the relative ratios of the electrolytes.
(2) Electrolytes in correct physiological quantities increase the efficiency of the body to utilize glycogen and improve muscular activities.
(3) Against the traditional concept that massive protein intake will efficiently increase muscular glycogen storage, experimentation in racing animals indicates that carbohydrates such as a simple combination of sucrose, glucose and citrate in the presence of electrolytes is a more efficient glycogen source. Carbohydrate as a glycogen source induces less stress in the metabolic system.
(4) The role of potassium is extremely important in oral electrolyte therapy to combat stress and in sugar absorption in the gastro intestinal tract. Clinical observations of racing animals and athletes performances indicates potassium deficiency is far more common. Supplementation in correct quantities and qualities reduces physical and metabolic stress and improves performance.
(5) Potassium otherthan in the form of potassium chloride induces potassium deficiency and alkalosis.
Use of potassium citrate, gluconate, carbonate or phosphate as the potassium source is not suitable.
(6) Oral magnesium has to be provided at a level of three times the required theoretical level as only one third is absorbed through the intestine.
(7) Supplementation of pyridoxine in high doses and in combination with ascorbic acid greatly reduces the stress effect on the metabolic system of the body by increasing the metabolic "Purification" process in the liver and kidney.
(8) Buffer agents can improve glycogen utilization.
(9) Physical stress induces metabolic alkalosis and not metabolic acidosis as commonly believed. The presence of acid in the urine does not conclude the body is acidotic.
(10) Hydrated ions such as phosphate ions cannot be replaced by their chemically equivalent anhydrous salt. e.g. Sodium phosphate B.P. (Na2HP04.
12H20) cannot be substituted by Na2HPO4 anhydrous.
Experimentation indicates that although both are chemically identical when dissolved in water, they do not perform the same physiologically. The water of crystallisation in the case of sodium phosphate B.P. is chemically attached to the phosphate ion. It is in such a form that the intracellular substrate can utilize the phosphate as a buffer. Dissolving sodium phosphate an hydros in water does not necessitate the attachment of water molecules to the phosphate ion. In fact this process of hydration is performed intracellularly, and requires energy. Ingestion of anhydrous sodium phosphate leads to additional stress on the intracellular substrate and dehydrates the cells. However if sodium phosphate B.P. is used as a source of phosphate and buffer, the intracellular substrate can utilize the available phosphate ion readily.
According to the present invention there is provided a mixture suitable for reconstituting with water to form a highly palatable drink which comprises sodium ions, potassium ions which have been derived from potassium chloride, magnesium ions, chloride ions, sulphate ions, phosphate ions as herein defined, citrate ions, sucrose, dextrose, ascorbic acid and pyridoxine, wherein the relative ratio ofthe ions sodium: potassium: magnesium: chloride: sulphate: phosphate is 5-7:3-5:1-3:5-6:1-3:5-7 calculated on a milliequivalent basis.
The phosphate ions referred to above and in the claims are defined as those ions which are produced upon the dissolution of hydrated disodium hydrogen phosphate and hydrated sodium dihydrogen phosphate in aqueous solution.
If desired a flavouring agent such as TRUSIL LEMON ELITE (the trade name of a commercial lemon flavouring agent supplied by Bush, Boake & BR< Allan), may be incorporated in the mixture to provide a particularly pleasant flavour on the palate.
Artificial sweeteners, colourings and preservatives may likewise be incorporated.
The phosphate and the citrate present in the mixture also function as a buffer system to maintain the drink within a desirable pH range. This pH range is preferably 6.8 to 7.4.
Preferably, the sucrose, dextrose and citrate is present in sufficient quantity to provide 3.4 Kcal of energy for every gram of mixture. This energy may be supplied by a mixture of 0.48 gram of sucrose, 0.318 gram of dextrose, 42 mg. of citric acid and 12 mg of sodium citrate.
The quantity of ascorbic acid is preferably 10 mg for every gram of concentrate and the pyridoxine is ideally present in an amount of 2.5 mg per gram of concentrate.
The drink which is produced from the mixture according to the present invention has the following properties: (a) There is no saline taste as in conventional electrolyte drinks.
(b) It is a complete electrolyte replacement in the sense that it caters for the complete needs of the body physiologically. The electrolytes presented are balanced to the natural body daily requirement. This enables the body to absorb and use the electrolyte raw material to repair or replenish any deficiency and aid the body to quick recovery from stress.
(c) It contains a series of simple carbohydrates, viz.
sucrose, dextrose and citrate, as a readily usable energy source. The body can make use of this immediately or build up the glycogen depot in the liver or muscles. The high glycogen level in the liver protects the liver and reduces cholesterol production.
(d) It provides a detoxifying effect mainly due to the presence of pyridoxine and ascorbic acid which aids the liverto efficiently metabolise and dispose unwanted harmful materials (alcohol, nitrogen waste etc.).
(e) The feeling of thirst, is stimulated both by a lower extracellular volume and a high plasma osmolarity. The present drink contains balanced electrolytes to provide for immediate adjustments, and hence satisfies the sensation of thirst (f) It provides potassium and sodium in its natural form of chlorides, and magnesium as sulphates as in the correct daily body requirement ratio. In addition, the phosphate rapidly helps to restore the body fluid to neutrality.
(g) It provides the blood with glucose. Unused glucose is automatically converted to glycogen and stored in the liver or muscle. It has generally been misunderstood that to increase glycogen storage to the maximum, vast quantities of protein should be ingested. However two convert protein to glycogen involves far more complicated and energy demanding metabolic processes. This is highly inefficient and wasteful of energy. In addition excess nitrogen waste from protein digestion also increases the demand, on the liver and kidney waste disposal system as excess nitrogen waste has to be dealt with to maintain the body free of metabolic alkalosis. In cases of potassium deficiency, the presence of ammonia enhances the metabolic alkalosis stress on the body buffering systems. In severe cases, this can be the major cause of kidney impairment.This fact has been repeatedly proven to be correct in racing greyhounds which have a diet consisting of a vast excess of meat and are subjected to severe racing stress.
(h) It improves the energy efficiency in the body. In Sydney University, athletes were required to perform a set work load in a given time under controlled laboratory conditions. Measurement of the heat generation by the body was used as a tool to meas ure the efficiency of the muscles to perform the work. The result was thatthe body temperature rise was significantly less when the present drink is ingested half an hour before the workout, as com pared to a salt and dextrose mixture, water, fruit juice, beer and a known brand of electrolyte supple ment. Body weight loss was also dramatically reduced.
(i) Potassium being a major intracellular compo nent is provided in drink formulation. A depletion of potassium leads to a decrease in action potential of muscle and also causes metabolic alkalosis. The present drink overcomes this problem.
(j) It supplies the two natural body buffers, viz. the phosphate buffer and the citrate buffer.
(k) It counteracts the effect of alcohol by providing vitamins B6 and C to aid alcohol metabolism in liver, increasing glycogen storage in the liver which acts as a protectant, replacing electrolytes lost, restoring the glucose level in the blood which supplies the brain, providing buffers to aid alcohol by-product disposal and neutralising excess gastric hydrochloric acid secretion caused by alcohol irritation on the stomach wall.
(I) Diarrhoea and vomiting causes severe dehydration through loss of water and electrolytes. The present drink replenishes such losses and restores body fluid volume and osmolarity.
(m) It is a balanced mineral source.
A preferred embodiment of the invention will now be described in the following example.
EXAMPLE A first mixture was prepared by blending 480 mg of disodium hydrogen phosphate (Na2HPO4 12H20) with 4.8 g of sucrose and 3.18 g of dextrose.
A second mixture was prepared by blending the following ingredients in the stated amounts.
Sodium Chloride 69.6 mg.
Potassium Chloride 288.0 mg.
Magnesium Sulphate (anhydrous) 148.0 mg.
Sodium Citrate 120.0 mg.
Sodium Acid Phosphate 111.6 mg.
Ascorbic Acid 100.0 mg.
Pyridoxine Hydrochloride 25.0 mg.
Citric Acid 420.0 mg.
Lemon Flavouring 257.8 mg.
The two mixtures were then blended together and milled to 100 mesh size to form a drink concentrate containing, for each 10 gm. 6.1 mEq sodium ions, 3.85 mEq potassium ions, 2.47 mEq magnesium ions, 5.0 mEq chloride ions, 2.47 mEq sulphate ions, 6.25 mEq phosphate ions, and 7.22 mEq citrate ions.
The product was a drink concentrate suitable for reconstituting with water to form a palatable drink.

Claims (11)

1. A mixture suitable for reconstituting with water to form a drink which comprises sodium ions, potassium ions which have been derived from potassium chloride, magnesium ions, chloride ions, sulphate ions, phosphate ions as herein defined, citrate ions, sucrose, dextrose, ascorbic acid and pyridoxine, wherein the relative ratio of the ions sodium: potassium: magnesium : chloride: sul phate: phosphate is 5-7 :3-5 : 3-5:1-3 : 5-6:1-3 : 5-7 calculated on a milliequivalent basis.
2. A mixture as claimed in claim 1 and including a flavouring agent.
3. A mixture as claimed in claim 1 or 2 and including an artificial sweetener and/or colouring and/or preservative.
4. A mixture as claimed in any of claims 1 to 3 which when reconstituted with water has a pH which is buffered within the range of 6.8 to 7.4.
5. A mixture as claimed in any one of claims 1-4 which contains a sufficient quantity of sucrose, dextrose and citrate to provide 3.4 Kcal of energy for every gram of mixture.
6. A mixture as claimed in claim 5 wherein for every gram of mixture there is 0.48 gram of sucrose, 0.31 gram of dextrose and 7.22 milliequivalents of citrate.
7. A mixture as claimed in any one of claims 1-6 wherein for every gram of mixture there is 10 mg of ascorbic acid and 2.5 mg of pyridoxine.
8. A mixture suitable for reconstituting with water to form a drink which comprises 6.1 mEq sodium ions, 3.85 mEq potassium ions, 2.47 mEq magnesium ions, 5.0 mEq chloride ions, 2.47 mEq sulphate ions, 6.25 mEq phosphate ions as herein defined, 7.22 mEq citrate ions, 100 mg ascorbic acid, 25 mg pyridoxine, 4.8 g sucrose, 3.1 g dextrose, and lemon flavouring q.s., per 10 grams of mixture.
9. A drink concentrate which comprises an admixture of sodium chloride potassium chloride anhydrous magnesium sulphate, hydrated disodium hydrogen, phosphate, hydrated sodium hydrogen phosphate, dextrose, sucrose, ascorbic acid, pyridoxine hydrochloride, sodium citrate and citric acid.
10. A drink concentrate as claimed in claim 9 wherein the ingredients are present in the following amounts (for each 10 gm.): Sodium Chloride 69.6 mg Potassium Chloride 288.0 mg.
Magnesium Sulphate 148.0 mg.
Sodium Citrate 120.0 mg.
Disodium hydrogen Phosphate 480.0 mg.
Sodium dihydrogen Phosphate 111.6 mg.
Ascorbic Acid 100.0 mg.
Pyridoxine Hydrochloride 25.0 mg.
Citric Acid 420.0 mg.
Sucrose 4.8 gm.
Dextrose 3.18 gm Lemon Flavouring 257.8 mg.
11. A mixture as claimed in claim 1 substantially as described in the Example.
GB7941451A 1978-12-11 1979-11-30 Electrolyte drink Expired GB2037565B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AU707778 1978-12-11

Publications (2)

Publication Number Publication Date
GB2037565A true GB2037565A (en) 1980-07-16
GB2037565B GB2037565B (en) 1983-03-23

Family

ID=3697684

Family Applications (1)

Application Number Title Priority Date Filing Date
GB7941451A Expired GB2037565B (en) 1978-12-11 1979-11-30 Electrolyte drink

Country Status (3)

Country Link
JP (1) JPS5581575A (en)
AU (1) AU526503B2 (en)
GB (1) GB2037565B (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085295A2 (en) * 1982-01-12 1983-08-10 Natrex Diätetika, E. Baltensperger Drinks and liquid foods with a low sodium level
EP0117653A1 (en) * 1983-02-01 1984-09-05 The Procter & Gamble Company Beverages containing specific cation-edible acid mixtures for improved flavor impression
EP0141250A2 (en) * 1983-10-10 1985-05-15 Natrex Diätetika, E. Baltensperger Beverage with a high magnesium content
US4853237A (en) * 1986-10-16 1989-08-01 Oy Sinebrychoff Ab Fitness drink powder
EP0353065A1 (en) * 1988-07-29 1990-01-31 University Of Florida Compositions and methods for achieving improved physiological response to exercise
US4994283A (en) * 1987-07-02 1991-02-19 The Procter & Gamble Company Iron-calcium mineral supplements with enhanced bioavailability
US5032411A (en) * 1990-02-27 1991-07-16 University Of Texas System Board Of Regents Beverage compositions for human consumption
EP1176948A4 (en) * 1999-05-03 2007-06-20 Drugtech Corp Anti-nausea compositions and methods
WO2022066868A1 (en) * 2020-09-25 2022-03-31 Abbott Laboratories Ready-to-drink carbonated electrolyte beverage

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE181988T1 (en) * 1984-11-23 1986-11-27 Aktiebolaget Pripps Bryggerier, Bromma PRODUCT FOR BEVERAGES.
JPH0256579U (en) * 1988-10-19 1990-04-24
US8034372B2 (en) * 2003-03-05 2011-10-11 Nestec, Ltd. Dietary supplement for athletic pets
WO2020209300A1 (en) * 2019-04-12 2020-10-15 サントリーホールディングス株式会社 Beverage containing sodium and organic acid
JP7211881B2 (en) * 2019-04-12 2023-01-24 サントリーホールディングス株式会社 Beverages containing sodium, potassium, and citric acid
JP7211879B2 (en) * 2019-04-12 2023-01-24 サントリーホールディングス株式会社 Beverage containing sodium and gluconic acid
JP7211880B2 (en) * 2019-04-12 2023-01-24 サントリーホールディングス株式会社 Beverage containing sodium, potassium and ascorbic acid

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0085295A2 (en) * 1982-01-12 1983-08-10 Natrex Diätetika, E. Baltensperger Drinks and liquid foods with a low sodium level
EP0085295A3 (en) * 1982-01-12 1984-03-21 Natrex Diatetika, E. Baltensperger Drinks and liquid foods with a low sodium level
EP0117653A1 (en) * 1983-02-01 1984-09-05 The Procter & Gamble Company Beverages containing specific cation-edible acid mixtures for improved flavor impression
EP0141250A2 (en) * 1983-10-10 1985-05-15 Natrex Diätetika, E. Baltensperger Beverage with a high magnesium content
EP0141250A3 (en) * 1983-10-10 1986-07-16 Natrex Diatetika, E. Baltensperger Beverage with a high magnesium content
US4853237A (en) * 1986-10-16 1989-08-01 Oy Sinebrychoff Ab Fitness drink powder
US4994283A (en) * 1987-07-02 1991-02-19 The Procter & Gamble Company Iron-calcium mineral supplements with enhanced bioavailability
EP0353065A1 (en) * 1988-07-29 1990-01-31 University Of Florida Compositions and methods for achieving improved physiological response to exercise
US5032411A (en) * 1990-02-27 1991-07-16 University Of Texas System Board Of Regents Beverage compositions for human consumption
EP1176948A4 (en) * 1999-05-03 2007-06-20 Drugtech Corp Anti-nausea compositions and methods
WO2022066868A1 (en) * 2020-09-25 2022-03-31 Abbott Laboratories Ready-to-drink carbonated electrolyte beverage

Also Published As

Publication number Publication date
AU526503B2 (en) 1983-01-13
JPS5581575A (en) 1980-06-19
AU5203579A (en) 1980-06-19
JPS6332766B2 (en) 1988-07-01
GB2037565B (en) 1983-03-23

Similar Documents

Publication Publication Date Title
US4322407A (en) Electrolyte drink
EP0040654B1 (en) Electrolyte drink concentrate
GB2037565A (en) Electrolyte drink
Passmore Handbook on human nutritional requirements
US6039987A (en) Physical endurance drink and method of preventing cramping caused by strenuous bodily activity
US5114723A (en) Beverage compositions for human consumption
JP3708115B2 (en) Mixed calcium and vitamin D supplements
US5032411A (en) Beverage compositions for human consumption
DE60008238T2 (en) COMPOSITIONS CONTAINING CREATINE IN THE FORM OF A SUSPENSION
CN101049150B (en) Edible nourishment health care potassium salt with extensive use
JPH07236460A (en) Creatine drink and its production
JPH09508804A (en) Sports Drink
CN103918965A (en) Physical fatigue alleviating beverage
US20060172016A1 (en) Muscle cramp reliever
KR20110013685A (en) A functional beverage comprising deep sea water, extract of fermented black ginger and extract of jujubae fructus as main ingredients
JP2004504824A (en) Fiber formula
JPH08224073A (en) Creatine veberage and its production
JPH09183732A (en) Potassium dominant non-solution pill and health promotion using the pill
JP3085889B2 (en) How to make jelly for energy supplementation
CN102715606A (en) Beverage
WO2001093692A2 (en) New canine beverage
RU2296491C1 (en) Beverage with pulp
JPS59203481A (en) Health carbonated drinking water
JPH05276904A (en) Beverage composition for young child
JP2564648B2 (en) Liquid food additive containing high concentration of ionized calcium, method for producing the same, and processed food to which the food additive is added

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19951130